Communications Biology · 2020 · 26 citations · 51 references
Life SciencesBiotechnologyMicrobiologyCell SignalingDrug DeliverySignal TransductionBacterial PathogenesisBacterial Secretion SystemsInnate Immune Signaling PathwaysProtein TargetingBacterial EffectorsEffector Delivery MechanismsIntracellular TargetsPathogen Effector ProteinsProtein Secretion SystemsSecreted Effector ProteinsSecretion System InhibitorsType Iii Secretion System Effectors
Protein-based affinity reagents (like antibodies or alternative binding scaffolds) offer wide-ranging applications for basic research and therapeutic approaches. However, whereas small chemical molecules efficiently reach intracellular targets, the delivery of macromolecules into the cytosol of cells remains a major challenge; thus cytosolic applications of protein-based reagents are rather limited. Some pathogenic bacteria have evolved a conserved type III secretion system (T3SS) which allows the delivery of effector proteins into eukaryotic cells. Here, we enhance the T3SS of an avirulent strain of Salmonella typhimurium to reproducibly deliver multiple classes of recombinant proteins into eukaryotic cells. The efficacy of the system is probed with both DARPins and monobodies to functionally inhibit the paradigmatic and largely undruggable RAS signaling pathway. Thus, we develop a bacterial secretion system for potent cytosolic delivery of therapeutic macromolecules.
51
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
J.M. Ostrem, Ulf Peters, Martin L. Sos et al. · Nature · 2013 · 2.5K citations · Full text
A Comprehensive Survey of Ras Mutations in Cancer
Ian A. Prior, Paul D. Lewis, Carla Mattos · Cancer Research · 2012 · 2.1K citations · Full text